Can a new anesthetic give older surgery patients a better Night's sleep?
NCT ID NCT07740343
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This trial tests whether remimazolam, an anesthetic drug, can improve sleep quality in older adults after laparoscopic colorectal cancer surgery, compared with the standard anesthetic propofol. Participants aged 65-80 will be randomly assigned to receive one of the two anesthetics during surgery. Sleep will be measured objectively using polysomnography (a gold-standard sleep test) on the first night after surgery, along with subjective sleep questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remimazolam
- What this could lead to
- If remimazolam preserves sleep quality better than propofol, it could become a preferred anesthetic for elderly patients, potentially aiding recovery after major surgery.
- What could go wrong
- This is a small, early-stage trial, and results may not apply to all patients. Sleep outcomes can vary widely, and the drug's benefits over propofol remain unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?